NCT00211159View on ClinicalTrials.gov

OmegAD (Omega-3 and Alzheimer's Disease)

NACompletedINTERVENTIONAL

Enrollment

204

Participants

Timeline

Start Date

December 31, 2000

Conditions

Alzheimer's Disease

Interventions

DRUG

EPAX 1050TG

Trial Locations (1)

S-141 86

Karolinska University Hospital Huddinge, Stockholm

All Listed Sponsors

lead

Karolinska University Hospital

OTHER

NCT00211159 - OmegAD (Omega-3 and Alzheimer's Disease) | Biotech Hunter | Biotech Hunter